Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-26 @ 4:06 AM
Study NCT ID:
NCT04233918
Status:
COMPLETED
Last Update Posted:
2024-07-16
First Post:
2020-01-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-06
First Submit QC Date:
None
Study First Post Date:
2020-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-04-19
Results First Submit QC Date:
None
Results First Post Date:
2023-06-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-06-07
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-06-25
Last Update Post Date:
2024-07-16
Last Update Post Date Type:
ACTUAL